Quest Diagnostics' stock price surged 5.32% in pre-market trading on Thursday, indicating strong investor interest ahead of the regular session.
The significant price movement appears to be driven by the company's latest quarterly results, which showed Q2 revenue of $3,043 million, surpassing analyst estimates of $2,967 million. This positive earnings surprise has likely boosted investor confidence in the company's financial performance.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.